Cases 21 - 30 of 200
Astellas Pharma Inc. et al v. Sandoz Inc.
as 1:2021cv00664
Plaintiff:
Astellas Pharma Inc., Astellas Pharma Global Development, Inc. and Astellas Ireland Co., Ltd.
Defendant:
Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Sandoz Inc. et al
as 1:2018cv00192
Defendant:
Fresenius Kabi Oncology Limited, Fresenius Kabi USA, Inc., Fresenius Kabi USA, LLC and others
Plaintiff:
Pharmacyclics LLC and Janssen Biotech Inc.
Counter Claimant:
Cipla USA Inc., Lek Pharmaceuticals d.d., Cadila Healthcare Limited and others
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Sandoz Inc. et al
as 1:2021cv00580
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Sandoz International GmbH and Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Amneal Pharmaceuticals LLC et al.
as 1:2017cv00823
Defendant:
TWi Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sawai Pharmaceutical Co., Ltd. and others
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Actavis LLC et al
as 1:2020cv00804
Defendant:
Hetero Labs Ltd., Belcher Pharmaceuticals, LLC, Glenmark Pharmaceuticals Ltd. and others
Plaintiff:
Sanofi Mature IP and Sanofi-Aventis U.S. LLC
Cause Of Action: 35 U.S.C. § 271
Novo Nordisk Inc. et al v. Sandoz Inc.
as 1:2020cv00747
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271
Exela Pharma Sciences, LLC v. Sandoz, Inc.
as 1:2020cv00645
Plaintiff:
Exela Pharma Sciences, LLC
Defendant:
Sandoz, Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Sun Pharma Global FZE et al
as 1:2020cv00403
Defendant:
Natco Pharma Ltd., Alvogen Pine Brook, LLC, Zydus Worldwide DMCC and others
Plaintiff:
Pharmacyclics LLC and Janssen Biotech, Inc.
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Sandoz Inc. et al
as 1:2019cv02080
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Sandoz International GmbH and Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. Aurobindo Pharma USA Inc.
as 1:2017cv00374
Defendant:
Aurobindo Pharma USA Inc., Indoco Remedies Ltd., Dr. Reddy's Laboratories Inc. and others
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
